Jump to content

Thailand Introduces Favipiravir Syrup


snoop1130

Recommended Posts

S__25067582-e1628140421446-1.jpg

 

Bangkok, Aug 5 (TNA) – The Chulabhorn Royal Academy (CRA) and the Faculty of Pharmaceutical Science at Chulalongkorn University introduced Thailand’s first favipiravir syrup for COVID-infected children and patients with swallowing difficulty.

 

CRA secretary-general Prof Dr Nithi Mahanonda said that during the present wave of COVID-19, 10% of patients were children and to survive they would need antiviral drug favipiravir within four days after developing severe symptoms.

 

According to him, Chulabhorn Hospital is capable of producing and distributing favipiravir syrup to about 300 patients per week. 

 

Full Story: https://tna.mcot.net/english-news-752955

 

tnalogo.jpg
Link to comment
Share on other sites

ability to treat 300 patients a weeks is a serious help when we have now over 20k daily (over 140k weekly) positives.

This antiviral, as well as all intivirals, suppose to be administered immediately on diagnosis. There is no point waiting for virus to multiply and develop serious state and still wait 4 days after that situation. Too late. 

Call yourself now Joke Academy and Faculty of Pharmaceutical Ignorance.

Why no scale up production 100 000 times and give it to everybody in small doses as preventative? And export it all over the world and finance buying more sinopharm?

As scientists they fail to be creative, imaginative and brave in this dramatic situation. They just thread what they were accustomed through their lives - utter passivity 

Edited by internationalism
  • Like 2
Link to comment
Share on other sites

Favipiravir possibly exerted no significant beneficial effect in the term of mortality in the general group of patients with mild to moderate COVID-19. We should consider that perhaps the use of antiviral once the patient has symptoms is too late and this would explain their low efficacy in the clinical setting.

Link to comment
Share on other sites

Stories like this are the result of the publisher telling editors that he's sick of bad news. (The publisher has the regime breathing down his neck).

 

 

6 minutes ago, rotorbreeze said:

Favipiravir possibly exerted no significant beneficial effect in the term of mortality in the general group of patients with mild to moderate COVID-19.

 

Favipiravir is used in both mild cases with patients who have co-morbidities, and severe pneumonia cases.

 

Chloroquine is also used. AS are: Lopinavir/Ritonavir or alternative regimens Darunavir/Ritonavir.

 

 

 

They don't really have an effective treatment, so trotting this out makes them feel like they're doing something (forgetting for a moment who's making money on this scheme), and fools most of the public into thinking they are using "science".

 

 

Did we expect anything different?

 

 

 

 

 

 

Link to comment
Share on other sites

14 hours ago, internationalism said:

ability to treat 300 patients a weeks is a serious help when we have now over 20k daily (over 140k weekly) positives.

This antiviral, as well as all intivirals, suppose to be administered immediately on diagnosis. There is no point waiting for virus to multiply and develop serious state and still wait 4 days after that situation. Too late. 

Call yourself now Joke Academy and Faculty of Pharmaceutical Ignorance.

Why no scale up production 100 000 times and give it to everybody in small doses as preventative? And export it all over the world and finance buying more sinopharm?

As scientists they fail to be creative, imaginative and brave in this dramatic situation. They just thread what they were accustomed through their lives - utter passivity 

If you read the article he is referring to children and patients with swallowing difficulties.

There are not 20k of those per day.

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.





×
×
  • Create New...